Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Pancreatic Neoplasms and DPYD[original query] |
---|
Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity. Chemotherapy 2010 56 (4): 313-7. Kim Suk-Ran, Park Chang-Hun, Park Silvia, Park Joon-Oh, Lee Jeeyun, Lee Soo-Yo |
Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Pancreas 2011 Jul 40 (5): 657-63. Zeng Hongmei, Yu Herbert, Lu Lingeng, Jain Dhanpat, Kidd Mark S, Saif M Wasif, Chanock Stephen J, Hartge Patricia, , Risch Harvey |
Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma. Frontiers in pharmacology 2018 9 1309. Velez-Velez Lisa M, Hughes Caren L, Kasi Pashtoon Murta |
Three different polymorphisms of the DPYD gene associated with severe toxicity following administration of 5-FU: a case report. Journal of medical case reports 2019 3 13 (1): 76. Mukherji Deborah, Massih Sarah Abdel, Tfayli Arafat, Kanso Mariam, Faraj Wal |
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 2021 Jan . Vivaldi Caterina, Crucitta Stefania, Catanese Silvia, Cucchiara Federico, Arrigoni Elena, Pecora Irene, Rofi Eleonora, Fornaro Lorenzo, Salani Francesca, Massa Valentina, Vasile Enrico, Morganti Riccardo, Danesi Romano, Del Re Marz |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: